This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Leidos Holdings, Inc. (LDOS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Leidos (LDOS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks.com featured highlights include Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare
by Zacks Equity Research
Halozyme Therapeutics, Leidos Holdings, Atmos Energy and Addus HomeCare have been highlighted in this Screen of The Week article.
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.
Leidos (LDOS) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Leidos (LDOS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks.com featured highlights include HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies
by Zacks Equity Research
HCA Healthcare, Taiwan Semiconductor Manufacturing, H&R Block, Leidos and The TJX Companies are part of the Zacks Screen of the Week article.
3 Reasons Why Growth Investors Shouldn't Overlook Leidos (LDOS)
by Zacks Equity Research
Leidos (LDOS) possesses solid growth attributes, which could help it handily outperform the market.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy Leidos (LDOS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Aerospace Stocks Lagging Leidos (LDOS) This Year?
by Zacks Equity Research
Here is how Leidos (LDOS) and Lockheed Martin (LMT) have performed compared to their sector so far this year.
Huntington Ingalls (HII) Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Huntington Ingalls (HII) Q2 revenues of $2.98 billion beat the Zacks Consensus Estimate by 4.7%. The company raised its 2024 revenue guidance for the Mission Technologies business segment.
5 Top-Ranked Dividend Stocks for Growth of Your Portfolio
by Sweta Killa
HCA Healthcare (HCA), Taiwan Semiconductor (TSM), H&R Block (HRB), Leidos Holdings. (LDOS) and The TJX Companies (TJX) could be solid choices for your portfolio.
Boeing's (BA) Q2 Earnings Miss Estimates, Revenues Decline Y/Y
by Zacks Equity Research
Boeing's (BA) Q2 revenues of $16.87 billion miss the Zacks Consensus Estimate by 3.5% and decline 15% from the year-ago quarter's reported figure.
Leidos Holdings (LDOS) Beats on Q2 Earnings, Ups '24 EPS View
by Zacks Equity Research
Leidos Holdings' (LDOS) Q2 revenues of $4.13 billion beat the Zacks Consensus Estimate by 2.2%. The top line also improves 7.7% year over year.
Leidos (LDOS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Leidos (LDOS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Leidos (LDOS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Leidos (LDOS) delivered earnings and revenue surprises of 16.37% and 2.23%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Leidos (LDOS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Leidos (LDOS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Will Segmental Sales Aid Huntington Ingalls' (HII) Q2 Earnings?
by Zacks Equity Research
Huntington Ingalls' (HII) Q2 results are likely to reflect a solid sales performance across its business segments, along with the benefits of margin improvement at its shipbuilding business.
4 Aerospace-Defense Stocks Poised to Beat on Q2 Earnings
by Aparajita Dutta
Second-quarter earnings for the Aerospace sector, which houses aerospace-defense stocks, are expected to have declined 2.3%. Let's see how LDOS, CW, ERJ & HII report.
Should Leidos (LDOS) Stock Be in Your Portfolio Pre-Q2 Earnings?
by Aparajita Dutta
Leidos' (LDOS) impressive earnings surprise history, anticipated notable growth from its sales and product diversity make it worth keeping in your portfolio ahead of its Q2 results.
Leidos Holdings, Inc. (LDOS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Leidos (LDOS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Northrop Grumman (NOC) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Northrop Grumman (NOC) delivered earnings and revenue surprises of 6.89% and 1.45%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Boeing (BA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Boeing (BA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Leidos (LDOS) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Leidos (LDOS) reachead $154.94 at the closing of the latest trading day, reflecting a +1.27% change compared to its last close.
Will Sales Volume Benefit L3Harris (LHX) in Q2 Earnings?
by Zacks Equity Research
L3Harris' (LHX) Q2 results are likely to reflect the benefits of strong sales volume growth and favorable synergies from the Aerojet acquisition amid the impact of higher interest expenses.